Product Information
EXEMESTANE 25 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.6119 per EA under NDC 59762285801. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
25 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762285801
Classification
Generic
Dosage Form
TABLET, SUGAR COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EXEMESTANEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020753On Market Since
4/1/2011
Pharmacological Classes
Price Statistics
The NADAC for EXEMESTANE 25 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 87.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6119 per EA |
|---|---|
| All-time high | $10.2171 (Aug 13, 2014) |
| All-time low | $0.5602 (Jul 17, 2024) |
| 52-week high | $0.8721 |
| 52-week low | $0.5751 |
| Median price | $2.4036 |
| Average price | $3.4790 |
| Largest weekly change | +63.5% (Apr 23, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EXEMESTANE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EXEMESTANE 25 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.6119 per EA (NDC 59762285801), effective Jun 24, 2026.
How has the price of EXEMESTANE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for EXEMESTANE 25 MG TABLET has declined 87.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EXEMESTANE 25 MG TABLET?
Since Nov 28, 2013, the NADAC for EXEMESTANE 25 MG TABLET has ranged from a low of $0.5602 (Jul 17, 2024) to a high of $10.2171 (Aug 13, 2014), with a median of $2.4036 per EA.
Are there cheaper alternatives to EXEMESTANE 25 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as EXEMESTANE 25 MG TABLET, but none are currently priced below it.
Who manufactures EXEMESTANE 25 MG TABLET?
EXEMESTANE 25 MG TABLET (NDC 59762285801) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification